Linagliptin Medochemie

Medicinal product

(Invented) name

Linagliptin Medochemie

Active substance (s)

Linagliptinas

Strength

5 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

A10BH05, Linagliptin

Marketing authorisation holder

Medochemie Ltd., Kipras

Date of authorisation

2024-09-09

Date of renewal

Documents

5547_Linagliptin Medochemie.docx

5547_pakuotes lapelis_2024-09-09.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

CY/H/0113/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Linagliptinas	5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
114872	100978	1100978	lizdinė plokštelė	N30		Receptinis	LT/1/24/5547/001	Netiekiama	-	2027-05-01	No	-	-
114874	100979	1100979	lizdinė plokštelė	N90		Receptinis	LT/1/24/5547/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2024-09-09	Registruotas